Last reviewed · How we verify
NCT05012709
A Study of Dose-response Relationship and the Evidence Based Multisensory Stimulation Intervention
NA trial testing multisensory stimulation therapy in Psychotic Disorders in 95 participants. Completed in 10 March 2013.
10 January 2013
Quick facts
| Lead sponsor | Jianan Psychiatric Center, Ministry of Health and Welfare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 95 |
| Start date | 15 March 2012 |
| Primary completion | 10 January 2013 |
| Estimated completion | 10 March 2013 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- multisensory stimulation therapy
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
- Anxiety — all drugs for Anxiety →
- Complementary Therapies — all drugs for Complementary Therapies →
- Clinical Trial — all drugs for Clinical Trial →
Sponsor
Jianan Psychiatric Center, Ministry of Health and Welfare
Who can join
Eligibility, any sex, with Psychotic Disorders or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Design: This parallel randomized controlled trial (RCT) was conducted according to the Consolidated Standards of Reporting Trials (CONSORT). Methods: In total, 90 patients were randomly assigned to either the intervention or the control group. After a 2-week washout period, the intervention group was reassigned to the control and vice versa. The CONSORT checklist for RCT was reported. Psychotic symptoms, emotional reactions, behavioral relaxation responses and heart rates were assessed at 6 time points.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05012709
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05012709 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jianan Psychiatric Center, Ministry of Health and Welfare
- Last refreshed: 19 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05012709.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing